Novo Integrated Sciences Stock Market Value
| NVOS Stock | USD 0 0.0004 12.90% |
| Symbol | Novo |
Is there potential for Health Care Providers & Services market expansion? Will Novo introduce new products? Factors like these will boost the valuation of Novo Integrated. Anticipated expansion of Novo directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Novo Integrated listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.33) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
Investors evaluate Novo Integrated Sciences using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Novo Integrated's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Novo Integrated's market price to deviate significantly from intrinsic value.
It's important to distinguish between Novo Integrated's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Novo Integrated should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Novo Integrated's market price signifies the transaction level at which participants voluntarily complete trades.
Novo Integrated 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Novo Integrated's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Novo Integrated.
| 11/09/2025 |
| 02/07/2026 |
If you would invest 0.00 in Novo Integrated on November 9, 2025 and sell it all today you would earn a total of 0.00 from holding Novo Integrated Sciences or generate 0.0% return on investment in Novo Integrated over 90 days. Novo Integrated is related to or competes with Sonendo. Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related p... More
Novo Integrated Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Novo Integrated's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Novo Integrated Sciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 50.33 | |||
| Information Ratio | 0.1975 | |||
| Maximum Drawdown | 983.87 | |||
| Value At Risk | (47.62) | |||
| Potential Upside | 110.0 |
Novo Integrated Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Novo Integrated's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Novo Integrated's standard deviation. In reality, there are many statistical measures that can use Novo Integrated historical prices to predict the future Novo Integrated's volatility.| Risk Adjusted Performance | 0.1696 | |||
| Jensen Alpha | 29.01 | |||
| Total Risk Alpha | 13.89 | |||
| Sortino Ratio | 0.5497 | |||
| Treynor Ratio | (1.75) |
Novo Integrated February 7, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1696 | |||
| Market Risk Adjusted Performance | (1.74) | |||
| Mean Deviation | 58.83 | |||
| Semi Deviation | 21.97 | |||
| Downside Deviation | 50.33 | |||
| Coefficient Of Variation | 504.82 | |||
| Standard Deviation | 140.1 | |||
| Variance | 19629.21 | |||
| Information Ratio | 0.1975 | |||
| Jensen Alpha | 29.01 | |||
| Total Risk Alpha | 13.89 | |||
| Sortino Ratio | 0.5497 | |||
| Treynor Ratio | (1.75) | |||
| Maximum Drawdown | 983.87 | |||
| Value At Risk | (47.62) | |||
| Potential Upside | 110.0 | |||
| Downside Variance | 2532.97 | |||
| Semi Variance | 482.89 | |||
| Expected Short fall | (124.91) | |||
| Skewness | 4.89 | |||
| Kurtosis | 26.07 |
Novo Integrated Sciences Backtested Returns
Novo Integrated is out of control given 3 months investment horizon. Novo Integrated Sciences has Sharpe Ratio of 0.2, which conveys that the firm had a 0.2 % return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 29.04% are justified by taking the suggested risk. Use Novo Integrated Sciences Mean Deviation of 58.83, risk adjusted performance of 0.1696, and Downside Deviation of 50.33 to evaluate company specific risk that cannot be diversified away. Novo Integrated holds a performance score of 16 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -15.86, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Novo Integrated are expected to decrease by larger amounts. On the other hand, during market turmoil, Novo Integrated is expected to outperform it. Use Novo Integrated Sciences sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to analyze future returns on Novo Integrated Sciences.
Auto-correlation | -0.2 |
Insignificant reverse predictability
Novo Integrated Sciences has insignificant reverse predictability. Overlapping area represents the amount of predictability between Novo Integrated time series from 9th of November 2025 to 24th of December 2025 and 24th of December 2025 to 7th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Novo Integrated Sciences price movement. The serial correlation of -0.2 indicates that over 20.0% of current Novo Integrated price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.2 | |
| Spearman Rank Test | -0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Novo Stock Analysis
When running Novo Integrated's price analysis, check to measure Novo Integrated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novo Integrated is operating at the current time. Most of Novo Integrated's value examination focuses on studying past and present price action to predict the probability of Novo Integrated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novo Integrated's price. Additionally, you may evaluate how the addition of Novo Integrated to your portfolios can decrease your overall portfolio volatility.